Notice bibliographique
- Notice
Type(s) de contenu et mode(s) de consultation : Texte noté : sans médiation
Titre(s) : Bioactive compounds against SARS-CoV-2 [Texte imprimé] / edited by Jen-Tsung Chen
Publication : Boca Raton : CRC press, copyright 2024
Description matérielle : 1 vol. (XVIII-275 p.) : ill. en coul. ; 29 cm
Note(s) : Notes bibliogr.
"Coronaviruses can cause illness, severe disease, and death; e.g. Middle East respiratory
syndrome (MERS), severe acute respiratory syndrome (SARS), and COVID-19. Vaccine development
and antiviral drugs are challenged by the propensity for viral mutations allowing
these viruses to evade such therapies"
Autre(s) auteur(s) : Chen, Jen-Tsung. Éditeur scientifique
Sujet(s) : Covid-19 -- Thérapeutique
Vaccins contre la Covid-19
Virus -- Résistance aux médicaments
Indice(s) Dewey :
614.592 4144 (23e éd.) = Covid-19 (incidence et mesures publiques de prévention)
Identifiants, prix et caractéristiques : ISBN 9781032347998 (rel.)
Identifiant de la notice : ark:/12148/cb47351991v
Notice n° :
FRBNF47351991
(notice reprise d'un réservoir extérieur)
Table des matières : <P>Chapter 1 ; Omics-guided intervention strategies in combatting SARS-CoV-2: Recent
advancements and challenges</P><P>Contributors: Somrita Padma, Nabarun Chandra Das,
Ritwik Patra, Pritha Chakraborty, Abhijit Dey, Suprabhat Mukherjee</P><P></P><P>Chapter
2 ; The application of computer-aided drug design methods for developing natural
compounds-based therapeutics against SARS-CoV-2</P><P>Contributors: Priya Godara,
Dhaneswar Prusty</P><P></P><P>Chapter 3 ; Therapeutic targets of host factors for
potential COVID-19 treatments</P><P>Contributors: Sabarinath Neerukonda</P><P></P><P>Chapter
4 ; Phytocompounds: A paradigm shift as therapeutics for COVID-19</P><P>Contributors:
Vijeta Prakash, Paridhi Bhatia, Shweta Dang, Pammi Gauba, Reema Gabrani</P><P></P><P>Chapter
5 ; Flavonoids as potential therapeutic agents against the SARS-CoV-2 infection:
An overview</P><P>Contributors: Anand Kumar Pandey, Shalja Verma</P><P></P><P>Chapter
6 ; Antiviral activities of flavonoids against COVID-19 and other virus-causing ailments</P><P>Contributors:
Arthi Boro, Biju Reji Souparnika, Srinivasan Atchaya, Shanmugam Ramya, Natchiappan
Senthilkumar, Shanmugam Velayuthaprabhu, Rengasamy Lakshminarayanan Rengarajan, Arumugam
Vijaya Anand</P><P></P><P>Chapter 7 ; Potential therapeutic effects of flavonoids
against the COVID-19 infection: The mode of action</P><P>Contributors: Aswani R.B,
Honey Pavithran , Ranjith Kumavath</P><P></P><P>Chapter 8 ; Terpene and Terpenoid:
Potent antiviral agents against SARS-CoV-2</P><P>Contributors: Dwaipayan Sinha, Moumita
Chatterjee, Srijonee Choudhury, Sanchita Seal, Tapas Das, Shilpi Sharma, Swastika
Banerjee, Shahana Chowdhury</P><P>Chapter 9 ; Phytonutrients and secondary metabolites
to cease SARS-CoV-2 loop</P><P>Contributors: Ajith Sivasangar Latha, Poornima Prasad
Anita, Nihala Sidhic, Elizabeth James, Mohandass Kaviya, Kathirvel Bharathi, Balasubramanian
Balamuralikrishna, Arumugam Vijaya Anand</P><P></P><P>Chapter 10 ; Treatment strategies
against COVID-19 using bioactive compounds and plant secondary metabolites</P><P>Contributors:
Syeda Aroosa Mohsin, Humaira Fatima, Rabia Javed</P><P></P><P>Chapter 11 ; The potential
contribution of vitamin K as a nutraceutical to scale down the mortality rate of COVID-19</P><P>Contributors:
Shanmugam Ramya, Arthi Boro, Irudhayaraj Peatrise Geofferina , Arumugam Jananisri
, Ganesh Vishalini , Balasubramanian Balamuralikrishnan, Meyyazhagan Arun, Arumugam
Vijaya Anand</P><P></P><P>Chapter 12 ; Gastrointestinal Symptoms in COVID-19 patients:
Prevention and Treatment</P><P>Contributors: Mohamed Bouhrim, Noureddine bencheikh
, Nour Elhouda Daoudi , Amine Elbouzidi , Hayat Ouassou , Loubna Kharchoufa , Doha
Berraaouan , Jen-Tsung Chen , Christophe Hano, Mohamed Addi , Mostafa Elachouri, Mohamed
Bnouham </P><P></P><P>Chapter 13 ; Mechanisms and management options of liver injury
in COVID19: A Review </P><P>Contributors: Daoudi Nour Elhouda, Bouhrim Mohamed, Bouziane
Omar, Mamri Samira, Marghich Mohamed, Ouassou Hayat, Mohamed addi, Christophe Hano,
Jen-Tsung Chen, Bnouham Mohamed</P><P></P><P>Chapter 14 ; Marine species-derived
bioactives against coronavirus disease</P><P>Contributors: Augustus Akshaya Rani,
Samsudeen Malik Basha, Syed Saadullah Ashfaq, Roy Apoorva, Jana Sudipta, Shunmugiah
Karutha Pandian</P><P></P><P>Chapter 15 ; Potential bioactive compounds of Indian
flora against SARS-CoV-2</P><P>Contributors: Deepyaman Das, Joydeep Chakraborty, Harshita
Shand, Rittick Mondal, Soumita Podder, Suvankar Ghorai, Amit Kumar Mandal</P><P>Chapter
16 ; Natural product-derived active compounds for the management of COVID-19: A summary
from Indochina</P><P>Contributors: Sora Yasri; Viroj Wiwanitkit</P><P></P><P>Chapter
17 ; Novel therapeutic strategy based on nanomedicine targeting thrombosis for SARSCoV-2
</P><P>Contributors: Xingping Quan, Xiaofeng Gong, and Yonghua Zhao</P><P></P><P>Chapter
18 ; Nanomaterials in combating human coronavirus infections</P><P>Contributors:
Mohanapriya Chelladurai, Renganathan Sahadevan, Sekar Vijayakumar</P><P></P><P>Chapter
19 ; Structural insights into drug targets from MERS, SARS-CoV, and SARS-CoV-2 and
scope for phytochemicals as broad-spectrum anti-virals and immunomodulators.</P><P>Contributors:
Nikhil Singh, Rafiq Mohamed, UV Babu, Raghavendra P Rao, Prachi Singh</P><P></P><P>Chapter
20 ; Precision phytochemicals for COVID-19-induced olfactory dysfunction</P><P>Contributors:
Sachiko Koyama, Vonnie D.C. Shields, Thomas Heinbockel</P>
